Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
about
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Risk factors for readmission i ...... ncology group study (ADS-1236)
@ast
Risk factors for readmission i ...... ncology group study (ADS-1236)
@en
type
label
Risk factors for readmission i ...... ncology group study (ADS-1236)
@ast
Risk factors for readmission i ...... ncology group study (ADS-1236)
@en
prefLabel
Risk factors for readmission i ...... ncology group study (ADS-1236)
@ast
Risk factors for readmission i ...... ncology group study (ADS-1236)
@en
P2093
P2860
P1433
P1476
Risk factors for readmission i ...... ncology group study (ADS-1236)
@en
P2093
James J Java
Linda R Duska
Robert A Burger
P2860
P304
P356
10.1016/J.YGYNO.2015.08.011
P407
P577
2015-08-31T00:00:00Z